𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Column liquid chromatography with diode laser-induced fluorescence detection of carboxylic acids after pre-column derivatisation

✍ Scribed by Arjan J.G. Mank; Marco C. Beekman; Nel H. Velthorst; Udo A.Th. Brinkman; Henk Lingeman; Cees Gooijer


Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
737 KB
Volume
315
Category
Article
ISSN
0003-2670

No coin nor oath required. For personal study only.

✦ Synopsis


Several pre-column approaches to fluorescence derivatisation of carboxylic acids, compatible with diode laser-induced fluorescence {DIO-LIF) detection, were compared. For this purpose red-absorbing labels containing hydrazide, bromoacetamide and iodoacetamide ftmctionalities were studied. The sensitivity of DIO-LIF detection is illustrated by the (3-10) X lo-" M (75-250 amol) detection limit for various derivatised carboxylic acids. The real-life detection limit for the carboxylic acids is 3 X lo-' M, because derivatisation is not quantitative at lower concentrations. Derivatised n-alkylcarboxylic acids and non-steroidal anti-inflammatory drugs are easily separated by column liquid chromatography, despite the attachment of the bulky red-absorbing labels. The dete~inarion of the anti-~~a~ato~ drug naproxen in saliva is shown as an example.


πŸ“œ SIMILAR VOLUMES


Determination of carboxylic acid salts i
✍ R. Gatti; E. Bousquet; D. Bonazzi; V. Cavrini πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 536 KB

2-Bromoacetyl-6-methoxynaphthalene (Br-AMN) was used as a fluorogenic labelling reagent for highperformance liquid chromatographic (HPLC) analyses of pyroglutamic acid, 4-hydroxybutyric acid and thioctic acid in pharmaceutical formulations. The reaction was carried out in aqueous medium in the prese

Further studies on the resolution of car
✍ Toshimasa Toyo'oka; Mumio Ishibashi; Tadao Terao πŸ“‚ Article πŸ“… 1993 πŸ› Elsevier Science 🌐 English βš– 854 KB

The optical purities of chiral derivatization reagents 4-(N,N-dimethylaminosulphonyl)\_7-(3-aminopyrrolidin-l-yl)-2,1,3-benzoxadiazole (DBD-APys), 4\_(aminosulphonyl)\_7-(3-aminopyrrolidin-1-yl)\_2,1,3-benzoxadiazole (ABD-APys) and 4-nitro-7-(3-aminopyrrolidin-1-ylJ-2,1,3-benzoxadiazole (NBD-APys) w